Omada Health Q2 revenue beats estimates on member growth

Omada Health

06/08/2026 21:32

Overview
US virtual healthcare provider's Q2 revenue grew 43% yr/yr, beating analyst expectations
Q2 adjusted EBITDA beat analyst estimates, reaching $11 mln
Company to appoint Wei-Li Shao as CEO, succeeding Sean Duffy in January 2027

Outlook
Omada Health raises 2026 revenue outlook to $334 mln-$340 mln, up from $322 mln-$330 mln
Company lifts 2026 adjusted EBITDA forecast to $21 mln-$27 mln, previously $14 mln-$20 mln
Company says raised outlook reflects strong Q2 performance and continued demand for its platform

Result Drivers
MEMBER GROWTH - Co said total members rose 45% yr/yr, citing continued demand for its integrated cardiometabolic care platform and strong enrollment in diabetes and hypertension programs
COMMERCIAL EXPANSION - Broadened partnership with Health Care Services Corporation extended programs to additional 1.5 mln covered lives, contributing to growth
NEW PROGRAM LAUNCH - First deployment of cholesterol management offering in July expanded personalized multi-condition care for a major retailer's employees

Company press release: ID:nGNX9s8swt

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$88 mln
$80.19 mln (11 Analysts)
Q2 EPS
 
$0.08
 
Q2 Net Income
 
$5 mln
 
Q2 Adjusted EBITDA
Beat
$11 mln
$3.42 mln (11 Analysts)
Q2 Adjusted Gross Margin
 
74%
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Omada Health, Inc. is $27.00, about 41.3% above its August 5 closing price of $19.11

Reuters Recommended Reads
Aug 4 - Hinge Health Q2 revenue jumps 53%, beats estimates
Aug 4 - Amwell Q2 revenue falls, co lifts low end of FY guidance 
Aug 6 - Evolent Health Q2 revenue beats expectations

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)